Many healthcare companies were seriously disrupted while dealing with the fallout from COVID-19. As vaccines get rolled out, momentum is likely to return.
In a year that has been so heavily dominated by healthcare due to the COVID-19 outbreak, there are many more health company losers than winners, with many being severely disrupted.
So says Yarra Capital Management head of small caps Katie Hudson. ASX heavyweights ResMed, CSL and Ramsay Health Care have suffered as the virus swept the world last year: ResMed lost out on new patient diagnoses for sleep apnoea (despite ventilator sales surging); CSL's plasma donations slowed; and Ramsay's hospitals were commandeered by governments as elective surgeries stopped for a period.
Loading...
Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
